Oppenheimer & Co’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Oppenheimer & Co’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-83	Closed	-$2K	–	1461
2022 Q3	$2K	Hold	83	–	–	﹤0.01%	1360
2022 Q2	$4K	Sell	83 -1	-1%	-$74	﹤0.01%	1403
2022 Q1	$12K	Hold	84	–	–	﹤0.01%	1460
2021 Q4	$14K	Hold	84	–	–	﹤0.01%	1483
2021 Q3	$42K	Hold	84	–	–	﹤0.01%	1472
2021 Q2	$42K	Hold	84	–	–	﹤0.01%	1493
2021 Q1	$42K	Hold	84	–	–	﹤0.01%	1422
2020 Q4	$40K	Buy	+84	New	+$27.6K	﹤0.01%	1332
2020 Q3	–	Sell	-34	Closed	-$6K	–	1363
2020 Q2	$6K	Hold	34	–	–	﹤0.01%	1248
2020 Q1	$4K	Hold	34	–	–	﹤0.01%	1188
2019 Q4	$6K	Hold	34	–	–	﹤0.01%	1271
2019 Q3	$5K	Hold	34	–	–	﹤0.01%	1251
2019 Q2	$4K	Hold	34	–	–	﹤0.01%	1299
2019 Q1	$6K	Hold	34	–	–	﹤0.01%	1343
2018 Q4	$4K	Hold	34	–	–	﹤0.01%	1235
2018 Q3	$5K	Hold	34	–	–	﹤0.01%	1346
2018 Q2	$22K	Sell	34 -43	-56%	-$32.2K	﹤0.01%	1317
2018 Q1	$78K	Buy	77 +10	+15%	+$8.37K	﹤0.01%	1293
2017 Q4	$81K	Hold	67	–	–	﹤0.01%	1281
2017 Q3	$12K	Hold	67	–	–	﹤0.01%	1286
2017 Q2	$10K	Hold	67	–	–	﹤0.01%	1293
2017 Q1	$16K	Hold	67	–	–	﹤0.01%	1281
2016 Q4	$18K	Hold	67	–	–	﹤0.01%	1270
2016 Q3	$15K	Hold	67	–	–	﹤0.01%	1260
2016 Q2	$26K	Hold	67	–	–	﹤0.01%	1205
2016 Q1	$45K	Hold	67	–	–	﹤0.01%	1210
2015 Q4	$70K	Hold	67	–	–	﹤0.01%	1232
2015 Q3	$58K	Buy	67 +34	+103%	+$28.4K	﹤0.01%	1297
2015 Q2	$24K	Hold	33	–	–	﹤0.01%	1460
2015 Q1	$75K	Sell	33 -34	-51%	-$58K	﹤0.01%	1433
2014 Q4	$69K	Buy	67 +33	+97%	+$35.3K	﹤0.01%	1351
2014 Q3	$35K	Buy	34 +1	+3%	+$1.68K	﹤0.01%	1395
2014 Q2	$84K	Hold	33	–	–	﹤0.01%	1360
2014 Q1	$64K	Buy	+33	New	+$78K	﹤0.01%	1368

Other funds holding AMPE

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ARG

Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Oppenheimer & Co's AMPE Position: Q4 2022 in Review

Oppenheimer & Co sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 83 shares — an estimated $2K sold.

Oppenheimer & Co first reported a position in AMPE in Q1 2014 and held it in 34 quarters. The position peaked at $84K in Q2 2014. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

Oppenheimer & Co reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
Oppenheimer & Co sold 83 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $2K.
Oppenheimer & Co first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 34 quarters.
Oppenheimer & Co's Ampio Pharmaceuticals Inc. position peaked at $84K in Q2 2014.
32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.